PAH

Medtronic wins FDA nod to deliver PAH therapy with implantable pump
Drug Delivery Business News
Tue, 07/31/18 - 09:57 am
Medtronic
FDA
drug delivery
United Therapeutics
PAH
Remodulin
devices
SynchroMed II
GSK-backed Liquidia takes a seat at the IPO table, looking for a $57.5M stake to take on United Therapeutics
Endpoints
Mon, 07/2/18 - 09:35 am
Liquidia
IPOs
PAH
United Therapeutics
Tyvaso
Pluristem Reports Positive Top-Line PhII Results From Its Placenta Derived Cell Therapy In Peripheral Artery Disease
CP Wire
Tue, 06/12/18 - 11:24 am
Pluristem
PLX-PAD
intermittent claudication
PAH
MannKind (MNKD) Completes Phase 1 Trial of Treprostinil Technosphere for PAH Advancing Development to Next Phase
Street Insider
Fri, 06/8/18 - 11:00 am
MannKind
TreT
FDA
PAH
Here's What Lifted Arena Pharmaceuticals, Inc. Stock in September
Motley Fool
Tue, 10/10/17 - 09:36 am
Arena Pharmaceuticals
ralinepag
PAH
pulmonary arterial hypertension
Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says
TheStreet.com
Mon, 07/17/17 - 07:05 pm
Arena Pharmaceuticals
ralinepag
PAH
pulmonary arterial hypertension
Arena takes a big step down the comeback trail with PhII success, shares rocket up
Endpoints
Tue, 07/11/17 - 11:18 am
Arena Pharmaceuticals
PAH
clinical trials
pulmonary arterial hypertension
ralinepag
How Is United Therapeutics’ Remodulin Positioned in 2017?
Market Realist
Mon, 07/3/17 - 09:46 am
United Therapeutics
Remodulin
PAH
pulmonary arterial hypertension
EMA panel recommends that use of Actelion's Uptravi may continue
Yahoo/Reuters
Sat, 02/11/17 - 12:32 pm
Europe
Actelion
Uptravi
pulmonary arterial hypertension
PAH
France
Actelion drug fails trial, denting revenue potential
Yahoo/Reuters
Mon, 01/23/17 - 10:19 am
Actelion
clinical trials
Opsumit
PAH
pulmonary arterial hypertension
J&J's $26 Billion Swiss Drugs Experiment
Bloomberg
Mon, 12/5/16 - 10:07 am
JNJ
Switzerland
Actelion
M&A
PAH
United Therapeutics sees stepped-up competition and says it's 'a good thing'
Bizjournals.com
Tue, 03/1/16 - 10:59 pm
United Therapeutics
PAH
pulmonary arterial hypertension
Could an old Roche arthritis med become a pioneering PAH treatment?
BioPharma Dive
Thu, 01/7/16 - 09:32 am
Roche
PAH
pulmonary arterial hypertension
tocilizumab
Actemra
Actelion sees Uptravi price of $160,000-170,000/patient
Yahoo/Reuters
Tue, 01/5/16 - 02:47 pm
Actelion
Uptravi
PAH
pulmonary arterial hypertension
Actelion says selexipag to enter U.S. market in January
Yahoo/Reuters
Tue, 12/22/15 - 10:56 am
Actelion
selexipag
Uptravi
PAH
pulmonary arterial hypertension
With Opsumit launch rolling, Actelion doesn't 'need' M&A: CEO
Fierce Pharma
Tue, 10/20/15 - 09:53 pm
Actelion
Opsumit
M&A
PAH
pulmonary arterial hypertension
Gilead Sciences Letairis Wins FDA Nod For PAH: Stock To Recover Soon
Bidness, ETC
Tue, 10/6/15 - 09:51 am
PAH
pulmonary arterial hypertension
FDA
Gilead Sciences
Letairis
Bellerophon shares skyrocket on high blood pressure drug study
Marketwatch
Thu, 09/24/15 - 07:19 pm
Bellerophon
PAH
Inopulse
clinical trials
pulmonary arterial hypertension
Actelion's Opsumit growth heralds smooth switch off aging Tracleer
Fierce Pharma
Tue, 07/21/15 - 10:34 am
Actelion
Opsumit
Tracleer
PAH
pulmonary arterial hypertension
Actavis seeking FDA Approval to market generic version of Gilead drug
Marketwatch
Fri, 04/3/15 - 10:35 am
Actavis
FDA
generics
Gilead Sciences
Letairis
PAH

Pages